NCT01595386View on ClinicalTrials.gov

Effect of Postop Steroids on Cardiovascular/Respiratory Function in Neonates Undergoing Cardiopulmonary Bypass

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Heart Disease Congenital Complex
Interventions
DRUG

Hydrocortisone

The drug will be bolused at 50mg/m2 followed by a continuous infusion that will start at 50mg/m2 for the first 48 hours and then be tapered as follows: 40mg/m2/day over 24 hours, 30mg/m2/day over 12 hours, 20 mg/m2/day over 12 hours, 10mg/m2/day over 24 hours, then off.

DRUG

Normal Saline

This will be bolused and infused in the same manner as the hydrocortisone arm to ensure blinding of study arm.

Trial Locations (1)

35233

University of Alabama at Birmingham, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER

NCT01595386 - Effect of Postop Steroids on Cardiovascular/Respiratory Function in Neonates Undergoing Cardiopulmonary Bypass | Biotech Hunter | Biotech Hunter